150 likes | 291 Views
. . . . Patient PopulationAdenocarcinoma of pancreasNo prior chemotherapyMeasurable or non-measurable diseaseEGFR status not an eligibility criterionStratification Center PS (0/1 vs 2) Stage of disease (Loc Adv / Metastatic). RANDOM I ZE. Gemcitabine 1000 mg/m2 over 30 minutes weekly
E N D